Devonian Health Group Inc (GSD) - Cash Flow Conversion Efficiency

Latest as of April 2026: -0.105x

Based on the latest financial reports, Devonian Health Group Inc (GSD) has a cash flow conversion efficiency ratio of -0.105x as of April 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-732.11K ≈ $-529.60K USD) by net assets (CA$6.98 Million ≈ $5.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see GSD market cap overview for the company's overall valuation and market capitalisation.

Devonian Health Group Inc - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Devonian Health Group Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Devonian Health Group Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Devonian Health Group Inc ranked by their cash flow conversion efficiency. Explore Devonian Health Group Inc earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Intrasoft Technologies Limited NSE:ISFT	0.038x
META ESTATE TRUST RO:MET	N/A
Toppoint Holdings Inc. NYSE MKT:TOPP	-0.023x
BlackRock Virginia MBT NYSE:BHV	0.012x
Citigold Corporation Limited F:CHP	-0.005x
Zodiac Energy Limited NSE:ZODIAC	-0.145x
PYRAMID AG NA O.N. XETRA:M3B	0.092x
LabGenomics Co. Ltd KQ:084650	-0.034x

Annual Cash Flow Conversion Efficiency for Devonian Health Group Inc (2015–2025)

The table below shows the annual cash flow conversion efficiency of Devonian Health Group Inc from 2015 to 2025. View GSD stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-07-31	CA$9.14 Million ≈ $6.61 Million	CA$-1.25 Million ≈ $-902.62K	-0.137x	-133.55%
2024-07-31	CA$13.86 Million ≈ $10.03 Million	CA$5.64 Million ≈ $4.08 Million	0.407x	+233.12%
2023-07-31	CA$14.25 Million ≈ $10.31 Million	CA$-4.36 Million ≈ $-3.15 Million	-0.306x	-73.26%
2022-07-31	CA$16.27 Million ≈ $11.77 Million	CA$-2.87 Million ≈ $-2.08 Million	-0.176x	+27.58%
2021-07-31	CA$7.52 Million ≈ $5.44 Million	CA$-1.83 Million ≈ $-1.33 Million	-0.244x	-12.78%
2020-07-31	CA$9.38 Million ≈ $6.79 Million	CA$-2.03 Million ≈ $-1.47 Million	-0.216x	-88.03%
2019-07-31	CA$10.08 Million ≈ $7.29 Million	CA$-1.16 Million ≈ $-837.62K	-0.115x	+31.72%
2018-07-31	CA$12.74 Million ≈ $9.21 Million	CA$-2.14 Million ≈ $-1.55 Million	-0.168x	+43.31%
2017-07-31	CA$8.19 Million ≈ $5.92 Million	CA$-2.43 Million ≈ $-1.76 Million	-0.297x	+42.78%
2016-07-31	CA$4.13 Million ≈ $2.99 Million	CA$-2.14 Million ≈ $-1.55 Million	-0.519x	-84.91%
2015-07-31	CA$5.19 Million ≈ $3.75 Million	CA$-1.46 Million ≈ $-1.05 Million	-0.281x	--

About Devonian Health Group Inc

V:GSD Canada Biotechnology

Market Cap

$18.00 Million

CA$24.89 Million CAD

Market Cap Rank

#25529 Global

#1006 in Canada

Share Price

CA$8.95

Change (1 day)

+3.77%

52-Week Range

CA$0.14 - CA$14.00

All Time High

CA$14.00